Elevated serum cortisol associated with early‐detected increase of brain amyloid deposition in Alzheimer's disease imaging biomarkers among menopausal women: The Framingham Heart Study
Authors:
Open Access
- 24 April 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (4) , e70179
Abstract
INTRODUCTION: This study investigates whether midlife cortisol levels predict Alzheimer's disease (AD) biomarker burden 15 years later, with particular attention to sex differences and menopausal status.METHODS: We analyzed data from 305 cognitively unimpaired Framingham Heart Study participants (48.5% female; mean age: 39.6 ± 8.1 years). Serum cortisol was categorized into tertiles, with amyloid ([11C]PiB) and tau ([18F]Flortaucipir) positron emission tomography (PET) imaging conducted 15 years later. We performed multivariable regression analyses adjusted for confounders including, apolipoprotein E4 (APOE4) status.RESULTS: Elevated midlife cortisol correlated with increased amyloid deposition, specifically in post‐menopausal women, predominantly in posterior cingulate, precuneus, and frontal‐lateral regions (p < 0.05). No significant associations were observed with tau burden or in males.DISCUSSION: These findings reveal post‐menopausal women with high midlife cortisol are at increased risk of AD. Results highlight the importance of identifying early risk factors when biomarkers are detectable but cognitive impairment is absent.Highlights: High midlife cortisol is linked to increased amyloid deposition in post‐menopausal women. Cortisol showed no association with tau pathology. Post‐menopausal hormone changes may amplify cortisol's effects on amyloid.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (N01‐HC‐25195, HHSN268201500001I, 75N92019D00031)
- National Institute on Aging (R01 AG054076, R01 AG049607, U01 AG052409, R01 AG059421, RF1 AG063507, RF1 AG066524, U01 AG058589)
- National Institute of Neurological Disorders and Stroke (R01 NS017950, UH2 NS100605)
- Alzheimer's Association (AARGD‐20‐685362)
- Health Research Board (CSF‐2020‐011)
- Texas Alzheimer's Research and Care Consortium (2020‐58‐81‐CR)
This publication has 59 references indexed in Scilit:
- An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestNeuroImage, 2006
- Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged MacaqueJournal of Neuropathology & Experimental Neurology, 2005
- Glucocorticoid-related genetic susceptibility for Alzheimer's diseaseHuman Molecular Genetics, 2003
- Alzheimer's Disease: Pathophysiological Implications of Measurement of Plasma Cortisol, Plasma Dehydroepiandrosterone Sulfate, and Lymphocytic Corticosteroid ReceptorsEndocrine, 2003
- Vienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation2002
- Altered circadian cortisol secretion in Alzheimer's disease: Clinical and neuroradiological aspectsJournal of Neuroscience Research, 2001
- Plasma cortisol levels in elderly female subjects with Alzheimer’s disease: a cross-sectional and longitudinal studyBrain Research, 2000
- Cortisol Secretion and Alzheimer’s Disease ProgressionBiological Psychiatry, 1997
- Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol.The Journal of Clinical Endocrinology & Metabolism, 1996
- Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's diseaseBiological Psychiatry, 1996